Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing dolutegravir (Tivicay®, Triumeq®, Juluca®): neural tube defects in babies whose mothers became pregnant while taking dolutegravir
2018.06.04
Active substance: dolutegravir
There are reports from an observational study on neural tube defects in babies, whose mothers became pregnant while taking dolutegravir.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN